Cosan Sets NYSE Delisting Date: ADS Trading to Cease September 18
CSAN is trading near its 52-week low of $2.38 (2.7% above the low).
Summary
Cosan has formally notified the NYSE of its plan to delist its ADSs, with the last trading day expected on September 18, 2026. The company will remain SEC-registered and continue reporting.
Key Events · Corporate Governance and Compliance · CSAN
-
NYSE Delisting Formalized
Following the Board resolution on August 14, 2026, Cosan formally notified the NYSE of its intention to voluntarily delist its ADSs.
-
Delisting Timeline Set
The Form 25 will be filed on September 8, 2026, and the last day of ADS trading on the NYSE is expected to be September 18, 2026.
-
SEC Registration Continues
After delisting, Cosan will remain registered under the Exchange Act and continue to comply with U.S. reporting obligations.
-
Capital Structure Simplification
The delisting is part of a broader effort to simplify the capital structure, reduce costs, and focus on strategic business areas, following the Radar II spin-off and executive changes announced on August 15.
Analysis · CSAN · Trade & Services
U.S. investors now have a firm deadline: Cosan has formally notified the NYSE of its plan to delist its ADSs, with the Form 25 filing scheduled for September 8, 2026, and the last trading day expected on September 18, 2026. The company will remain registered under the Exchange Act and continue to meet its reporting obligations. This step is part of a broader simplification of the capital structure, coming on the heels of the CFO and CLO resignations and the Radar II spin-off announced days earlier. For U.S. holders, the delisting removes a liquid trading venue for the ADSs, potentially reducing liquidity and access, even though the primary listing on B3 remains. With the stock trading near its 52-week low, the pressure is on for U.S. investors to act before the delisting date.
At the time of this filing, CSAN was trading at $2.44 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $2.38 to $6.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.